Yusuke Kamada

960 citations

23 papers · 634 indexed · h-index 15

Impact in

Molecular Biology
- Protein Kinase Regulation and GTPase Signaling
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- DNA Repair Mechanisms
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- RNA modifications and cancer
Oncology
- Peptidase Inhibition and Analysis

Papers in

Internal Medicine 1
Molecular Biology 18
- RNA and protein synthesis mechanisms 3
- Glycosylation and Glycoproteins Research 2
- Biochemical and Molecular Research 2
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Kinase Regulation and GTPase Signaling 2
- Cancer-related gene regulation 2

Co-authors: Kotaro Sakamoto Satoshi Sogabe Junichi Sakamoto Akiyoshi Tani Masanori Miwa Masahiro Kamaura Tomoya Sameshima Ayumu Niida
Journals: Biochemical and Biophysical Research Communications (6 papers)Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry (2 papers)Pharmacology (1 paper)Drug Discoveries & Therapeutics (1 paper)
Partner nations: Japan United States Canada

In The Last Decade

Yusuke Kamada

23 papers receiving 628 citations

Peers

Countries citing papers authored by Yusuke Kamada

Since Specialization

Citations

This map shows the geographic impact of Yusuke Kamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Kamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Kamada more than expected).

Fields of papers citing papers by Yusuke Kamada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Kamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Kamada. The network helps show where Yusuke Kamada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yusuke Kamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yusuke Kamada Line = papers co-authored together Yusuke Kamada links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Proposal of an <i>in vitro</i> thrombus-growth model for evaluating anticoagulants Drug Discoveries & Therapeutics ·沈栋娟, Hiroyuki Yamamoto, Jana Brandstätter, Ken Tachibana, Jérôme Ploquin, Yusuke Kamada, Takanori Nakajima	2022	1
2	Biochemical Properties of TAK-828F, a Potent and Selective Retinoid-Related Orphan Receptor Gamma t Inverse Agonist Pharmacology ·Hideyuki Nakagawa, Echeverría Abularach, Yusuke Kamada, Atsuko Ochida, Léo Humbert, Junya Shirai, Satoshi Yamamoto, Luis Francisco Javier Ruffin Villaoslada, Bi‐Ching Sang, Masaaki Nakayama	2018	8
3	T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice Neuropsychopharmacology ·Satoru Matsuda, Catherine Mathebula, Hideyuki Oki, Shinji Morimoto, Didar K. Azizkhanova, S. Igaki, Yusuke Kamada, Shinji Iwasaki, Luana Ely Farias de Souza, Noora Heiskanen, عبدالواحد غازي النعيمي, Takeshi Hirakawa, Misa Iwatani, Ken Tsuchida, Ryujiro Hara, Mitsuhiro Ito, Haruhide Kimura	2018	38
4	Discovery of artificial VIPR2-antagonist peptides possessing receptor- and ligand-selectivity Biochemical and Biophysical Research Communications ·Kotaro Sakamoto, Ryokichi Koyama, Yusuke Kamada, Masanori Miwa, Akiyoshi Tani	2018	12
5	LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B Cancer Research ·Shinji Takagi, Yoshinori Ishikawa, Akio Mizutani, Shinji Iwasaki, Satoru Matsumoto, Yusuke Kamada, Toshiyuki Nomura, Kazuhide Nakamura	2017	66
6	Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors Journal of Medicinal Chemistry ·Masahiro Ito, Toshio Tanaka, Douglas R. Cary, И. И. Бондарчук, Yusuke Kamada, Tomohiro Kawamoto, Samuel Aparício, Atsushi Nakanishi, Yasuhiro Imaeda	2017	28
7	Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design Bioorganic & Medicinal Chemistry ·Takeshi Yasui, Takeshi Yamamoto, Nozomu Sakai, George S. Firlit, Takafumi Takai, Berrin Yaniko, L.C. Fernandes, Terufumi Takagi, Kotaro Sakamoto, Satoshi Sogabe, Yusuke Kamada, Weston Lane, Gyorgy Snell, Masashi Iwata, Laura Cormier, Hiroshi Inooka, Junichi Sakamoto, Shouzou YAMAMOTO, Yasuhiro Imaeda	2017	21
8	Identification of cytidine-5-triphosphate synthase1-selective inhibitory peptide from random peptide library displayed on T7 phage Peptides ·Kotaro Sakamoto, Yoshihiro Ishibashi, Ryutaro Adachi, Shin-ichi Matsumoto, Hideyuki Oki, Yusuke Kamada, Satoshi Sogabe, محمد أحمد عقلان, Junichi Sakamoto, Akiyoshi Tani	2017	6
9	Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization Biochemical and Biophysical Research Communications ·Satoshi Sogabe, Kotaro Sakamoto, Yusuke Kamada, დავით საბელაშვილი, Widya Sri Ramadhani, Junichi Sakamoto	2017	11
10	Discovery of selective ATP-competitive eIF4A3 inhibitors Bioorganic & Medicinal Chemistry ·Masahiro Ito, Misa Iwatani, Yusuke Kamada, Satoshi Sogabe, Gilda Galope Lum, Toshio Tanaka, Tomohiro Kawamoto, Samuel Aparício, Atsushi Nakanishi, Yasuhiro Imaeda	2017	26
11	A pyridone derivative activates SERCA2a by attenuating the inhibitory effect of phospholamban European Journal of Pharmacology ·Zhang Xintan, Xie Yong, Kou Hirai, Yusuke Kamada, Toshiki Tanaka, Azlan Ariff Aizuddin, S. Yamamoto, Fu Zhangjing, Joanna Williams, 柏井世次, Masakuni Noda, Makoto Inui, Tomoyuki Nishimoto	2017	14
12	Identification of ligand-selective peptidic ActRIIB-antagonists using phage display technology Biochemistry and Biophysics Reports ·Kotaro Sakamoto, Fatima-Ezzahra Eddaoudi, Yusuke Kamada, Masahiro Oka, Toshiyuki Ohnishi, Masanori Miwa, Taiji Asami, Hiroshi Inooka	2017	7
13	K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology Biochemical and Biophysical Research Communications ·Kotaro Sakamoto, Yusuke Kamada, Tomoya Sameshima, 正明竹中, Ayumu Niida, Shigekazu Sasaki, Masanori Miwa, Shoichi Ohkubo, Junichi Sakamoto, Masahiro Kamaura, Nobuo Cho, Akiyoshi Tani	2017	88
14	Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship Biochemical and Biophysical Research Communications ·Kotaro Sakamoto, Satoshi Sogabe, Yusuke Kamada, Nozomu Sakai, George S. Firlit, Núria Porcar, Ailamazyan A.M., Yasuhiro Imaeda, Junichi Sakamoto	2016	26
15	Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration Biochemical and Biophysical Research Communications ·Kotaro Sakamoto, Yusuke Adachi, Yusaku Komoike, Yusuke Kamada, Ryokichi Koyama, Widya Sri Ramadhani, დავით საბელაშვილი, Taiji Asami, Junichi Sakamoto	2016	20
16	Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis Biochemical and Biophysical Research Communications ·Kotaro Sakamoto, Satoshi Sogabe, Yusuke Kamada, Shin-ichi Matsumoto, დავით საბელაშვილი, Junichi Sakamoto, Akiyoshi Tani	2016	46
17	Hes1 suppresses acute myeloid leukemia development through FLT3 repression Leukemia ·Takeharu Kato, Mamiko Sakata‐Yanagimoto, Hidekazu Nishikii, Masaya Ueno, Y. Miyake, Yasuhisa Yokoyama, Saber Askari, Yusuke Kamada, Hideharu Muto, Naoshi Obara, Kazumi Suzukawa, 高俊林, Issay Kitabayashi, Koichiro Uchida, Atsushi Hirao, Hideo Yagita∥, Ryoichiro Kageyama, Shigeru Chiba	2014	34
18	A Fragment-Based Approach to IdentifyingS-Adenosyl-l-methionine -Competitive Inhibitors of CatecholO-Methyl Transferase (COMT). Journal of Medicinal Chemistry ·Marion Lanier, Géza Ambrus, Derek C. Cole, Richard Davenport, Чекалина Ангелина Анатольевна, Richard Fosbeary, Andy Jennings, დავით საბელაშვილი, Yusuke Kamada, Ruhi Kamran, Shin-ichi Matsumoto, Atsushi Mizukami, Andrew E. Jacob, Kengo Okada, Kumar Singh Saikatendu, 茂樹小澤, Haihong Wu, Mark S. Hixon	2014	10
19	Functional and Physical Interaction of Yeast Mgs1 with PCNA: Impact on RAD6 -Dependent DNA Damage Tolerance Molecular and Cellular Biology ·Takashi Hishida, Florian Ernst, Yoshino Kubota, Yusuke Kamada, Hideo Shinagawa	2006	53
20	Determination of allelopathic potential of young and mature Digitaria adscendens on crop growth. Journal of Weed Science and Technology ·Misako Ito, Yusuke Kamada, L. Nalmo	1986	4

About Yusuke Kamada

Yusuke Kamada is a scholar working on Internal Medicine, Molecular Biology, Oncology, Hematology and Biochemistry, having authored 23 papers that have together received 634 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (3 papers), Glycosylation and Glycoproteins Research (2 papers), Biochemical and Molecular Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Cancer-related gene regulation (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Molecular Biology (497 citations), Oncology (125 citations), Cancer Research (52 citations), Hematology (28 citations) and Organic Chemistry (59 citations). Yusuke Kamada has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Kotaro Sakamoto, Satoshi Sogabe, Junichi Sakamoto, Akiyoshi Tani, Masanori Miwa, Masahiro Kamaura, Tomoya Sameshima, Ayumu Niida, Shigekazu Sasaki and Yasuhiro Imaeda. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Pharmacology and Drug Discoveries & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact